Endoscopic Retrograde Cholangiopancreaticography
ProcedureAnaesthesia or sedation during ERCP for common bile duct stones
NCT Number: NCT07205380
Endoscopic retrograde cholangiopancreatography (ERCP) for common bile duct stones (CBDS) removal can be performed under varying levels of sedation. Deeper sedation has been associated with more successful cannulation, but little is known about the efficacy of ERCP measured as rate of retained CBDS depending on the level of sedation.
In this population-based, cohort study, using prospectively assembled register data from 121 252 ERCP procedures, adjusted odds ratio (OR) of retained CBDS 12 months after CBDS removal are analysed. Retained CBDS are defined as a repeated ERCP where CBDS are found.
Looking for future studies?
Notify MeAll sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Anaesthesia or sedation during ERCP for common bile duct stones
Time frame: 12 months
Retained common bile duct stones necessitating repeated ERCP within 12 months after the first ERCP
Karolinska Institutet
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05928286
Biliary Tract Diseases, Cholelithiasis
Barnaul, Russia
View Trial DetailsNCT04406961
Benign Biliary Strictures With Current or Prior Biliary Obstruction, Bile Duct Diseases
Odesa, Odesa Oblast, Ukraine
View Trial DetailsNCT06258824
Adenocarcinoma, Ampullary Cancer
London, United Kingdom
View Trial DetailsNCT02351492
Bile Duct Diseases, Biliary Tract Diseases
Basel, Switzerland
View Trial Details